Biogen (BIIB) Total Debt (2016 - 2025)
Historic Total Debt for Biogen (BIIB) over the last 16 years, with Q4 2025 value amounting to $6.3 billion.
- Biogen's Total Debt fell 14.3% to $6.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $6.3 billion, marking a year-over-year decrease of 14.3%. This contributed to the annual value of $6.3 billion for FY2025, which is 14.3% down from last year.
- As of Q4 2025, Biogen's Total Debt stood at $6.3 billion, which was down 14.3% from $150.0 million recorded in Q2 2025.
- Biogen's Total Debt's 5-year high stood at $6.9 billion during Q4 2023, with a 5-year trough of $150.0 million in Q2 2025.
- In the last 5 years, Biogen's Total Debt had a median value of $6.3 billion in 2022 and averaged $4.5 billion.
- Per our database at Business Quant, Biogen's Total Debt soared by 52866.58% in 2022 and then plummeted by 925.89% in 2024.
- Quarter analysis of 5 years shows Biogen's Total Debt stood at $999.1 million in 2021, then surged by 528.67% to $6.3 billion in 2022, then grew by 10.46% to $6.9 billion in 2023, then dropped by 9.26% to $6.3 billion in 2024, then dropped by 0.14% to $6.3 billion in 2025.
- Its Total Debt stands at $6.3 billion for Q4 2025, versus $150.0 million for Q2 2025 and $6.3 billion for Q4 2024.